Pulmonology Advisor interviewed David Van Sickle, a former Epidemic Intelligence Service officer at the US Centers for Disease Control and Prevention (CDC) and now CEO of Propeller Health, about addressing adherence-demanding situations in bronchial asthma and chronic obstructive pulmonary disease (COPD), the effects of weather trade on each condition, and future directions of research.
Editor’s Note: This interview was edited for duration and readability.
Pulmonology Advisor: What are some of the technologies Propeller Health is operating on to improve the lives of sufferers with allergies or COPD? David Van Sickle: Asthma and COPD represent 2 of the most frustrating challenges in health care. In the past one hundred years, we’ve made big leaps in developing new drug treatments and information on the complexity of sicknesses. Yet, today, patients aren’t doing in addition to what they might be, and doctors no longer have the equipment they need to supply more customized treatment.
Sadly, each patient and clinician have lowered their expectations for the existence of allergies and COPD.
What’s greater, the stakes for these diseases are huge. Approximately 235 million humans internationally have bronchial asthma, and COPD may be the main cause of death by 2030.1,2 Patients’ lives are interrupted continuously with the aid of these diseases via overlooked faculty, neglected paintings, and missed moments with their own family and friends. This affects healthcare gadgets because the shortage of preventive control results in high costs for medical institution utilization. As the effects of climate trade worsen, the air becomes more unbreathable, developing the situation for a chief public fitness disaster.
Through the Propeller platform. This is where Propeller is available. Propeller helps relieve the burden of allergies and COPD by giving sufferers and their carriers a tool that provides consistent care through their telephone or computer. Three patients no longer must wait three months to peer their doctor and conflict to remember how they had been using their medicines; alternatively, Propeller connects their existing inhaler to their cellphone through a small sensor and grants insights on symptoms and triggers and medicine used to the Propeller app.
Sufferers obtain reminders to take medicine, forecasts on allergy conditions, and tips for lowering signs.
The Propeller can monitor an affected person’s maximum, not unusual, environmental triggers, assisting them in avoiding flare-ups. S.A.In an increasingly unbreathable global. With the affected person’s consent, the platform can speak with the affected person’s physician to reveal how the patient is doing during appointments.
Pulmonology Advisor: Do the sensors attached to inhalers also degree adherence to medicine?
